Northeast Pharmaceutical Group Co., Ltd.

SZSE:000597.SZ

5.01 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993
Revenue 8,161.4288,808.9438,145.1177,384.3548,220.1037,466.5555,676.3524,814.4023,834.4324,333.3223,870.5913,864.9133,882.784,828.7465,093.5884,609.7733,706.0741,918.2381,833.0771,619.6871,606.8771,396.9821,441.981,197.5681,011.546760.618757.4521,166.0751,049.725934.5911,001.844
Cost of Revenue 5,021.2125,377.3944,928.9384,492.6724,637.9944,377.1913,431.7993,295.1172,817.1372,967.0582,675.822,908.4463,090.1663,697.8413,535.8723,031.5242,983.6791,497.6271,410.6051,243.7321,227.1951,111.5111,131.753897.565734.714560.429608.2131,018.179891.206716.583727.059
Gross Profit 3,140.2163,431.5493,216.182,891.6823,582.1093,089.3642,244.5531,519.2841,017.2951,366.2641,194.771956.467792.6131,130.9051,557.7171,578.25722.395420.611422.472375.955379.683285.47310.227300.003276.832200.189149.24147.895158.519218.008274.785
Gross Profit Ratio 0.3850.390.3950.3920.4360.4140.3950.3160.2650.3150.3090.2470.2040.2340.3060.3420.1950.2190.230.2320.2360.2040.2150.2510.2740.2630.1970.1270.1510.2330.274
Reseach & Development Expenses 86.606160.38983.45974.18163.938144.6757.65730.926.25918.79115.600000000000000000000
General & Administrative Expenses 271.054267.928307.803304.663190.133144.144273.408141.735202.078182.989235.501262.742347.812222.768409.041348.096192.954172.517193.913173.492170.615104.745116.434135.648123.61753.44167.8378.49955.85874.97593.766
Selling & Marketing Expenses 1,809.7172,050.9012,016.3071,744.8772,295.2061,918.2881,121.589737.165632.683636.651590.934522.487420.228423.356458.127341.905245.346164.397137.378123.145140.712102.62590.79374.51152.80330.84323.06336.13136.79529.94629.646
SG&A 2,499.152,318.8292,324.112,049.5412,485.342,062.4321,394.997878.9834.761819.64826.434785.229768.04646.124867.168690.001438.3336.914331.291296.637311.328207.37207.227210.159176.4284.28490.893114.6392.654104.921123.412
Other Expenses -188.088498.236452.333442.046584.89137.775-12.35943.3526.468112.62144.592377.3389.00798.74871.9965.44631.5158.409-11.397-3.9570.904-0.713-4.4771.93823.09914.999-72.366-0.14212.4079.9944.846
Operating Expenses 2,773.8452,977.4542,859.9022,565.7683,134.1672,617.6641,878.8141,323.6641,214.1481,181.971,227.6711,116.9661,103.198951.243905.004723.706452.824344.649341.897301.215314.952212.391212.009214.319181.10685.99393.095115.84493.804108.263181.21
Operating Income 366.371367.382348.344279.04489.33775.961114.5321.597-403.1667.149-202.884-332.399-469.62237.869532.4494.953101.97851.68748.8530.6098.36514.42125.55337.73848.90477.86413.00625.54749.40972.3647.489
Operating Income Ratio 0.0450.0420.0430.0380.060.010.020-0.1050.002-0.052-0.086-0.1210.0080.1050.1070.0280.0270.0270.0190.0050.010.0180.0320.0480.1020.0170.0220.0470.0770.047
Total Other Income Expenses Net 121.801158.059-228.181-187.202-265.092-257.964-263.567-158.192-210.04-78.546-126.064202.951-70.651-102.519-68.334-354.868-137.648-38.842-39.065-40.452-65.748-75.015-76.187-52.174-66.943-45.872-135.268-10.34-8.232-43.855-39.068
Income Before Tax 488.172525.441120.16391.838224.245213.736102.17337.428-406.892105.748-158.96442.452-381.23677.142584.378499.675131.92348.60839.48130.474.1265.88621.55336.59350.39380.594-69.24223.55959.14974.12253.421
Income Before Tax Ratio 0.060.060.0150.0120.0270.0290.0180.008-0.1060.024-0.0410.011-0.0980.0160.1150.1080.0360.0250.0220.0190.0030.0040.0150.0310.050.106-0.0910.020.0560.0790.053
Income Tax Expense 112.194168.39324.72281.01153.80512.36710.11511.083-14.74221.9276.23637.0250.23623.303108.295141.73884.9328.98226.1322.3428.791-4.20711.4837.757.01312.426-53.023.61412.04510.99.407
Net Income 358.458350.25399.02712.257173.978195.2118.99523.788-384.35887.075-166.9638.104-389.96150.011476.079357.90647.52119.62613.3518.1298.68510.1910.11328.85143.37968.166-69.24219.94547.10563.22244.014
Net Income Ratio 0.0440.040.0120.0020.0210.0260.0210.005-0.10.02-0.0430.002-0.10.010.0930.0780.0130.010.0070.0050.0050.0070.0070.0240.0430.09-0.0910.0170.0450.0680.044
EPS 0.250.260.0740.010.140.160.110.023-0.360.099-0.230.009-0.530.0720.640.520.070.0370.0140.0070.010.0110.0040.0210.0470.039-0.10.0220.0670.0940.065
EPS Diluted 0.250.260.0740.010.140.160.110.023-0.360.099-0.230.009-0.530.0720.640.520.070.0370.0140.0070.010.0110.0040.0210.0470.039-0.10.0220.0670.0940.065
EBITDA 941.45928.488899.256759.797829.718952.575692.03581.30872.385484.544164.097380.981-5.124464.361855.538943.178386.384168.181162.918140.004135.317134.276144.461138.852131.954156.70756.14532.05164.715109.74593.575
EBITDA Ratio 0.1150.1050.110.1030.1010.1280.1220.1210.0190.1120.0420.099-0.0010.0960.1680.2050.1040.0880.0890.0860.0840.0960.10.1160.130.2060.0740.0270.0620.1170.093